RMI welcomes panel report
RMI welcomes panel report
“The Researched Medicines Industry Association (RMI) welcomes the publication today of the Review of Access to High-Cost, Highly Specialised Medicines in New Zealand, released by the Hon Tony Ryall, Minister of Health.
“We will be taking time to study the recommendations in detail but we are encouraged that the panel have listened carefully and objectively to all the submissions made” says Denise Wood, Chief Executive.
“The PHARMAC model needs to evolve in order to address the ever increasing gap between New Zealand and the rest of the world in terms of access to medicines; the RMI looks forward to working with the Government on taking these recommendations forward.”
ENDS